Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.0012 USD | 0.00% |
|
-47.83% | -98.06% |
2023 | Psycheceutical Bioscience, Inc. kündigt Wechsel im Vorstand an | CI |
2023 | Psycheceutical Bioscience, Inc. ernennt Neilank K. Jha zum neuen Executive Chairman | CI |
1 Woche | -47.83% | ||
Aktueller Monat | -60.00% | ||
3 Monate | -95.06% | ||
6 Monate | -97.66% | ||
Laufendes Jahr | -98.06% |
![Kursextrem 0.0012](/images/extremecours_fleche.png)
![Kursextrem 0.0012](/images/extremecours_fleche.png)
![Kursextrem 0.0012](/images/extremecours_fleche.png)
![Kursextrem 0.0012](/images/extremecours_fleche.png)
![Kursextrem 0.0012](/images/extremecours_fleche.png)
![Kursextrem 0.0012](/images/extremecours_fleche.png)
![Kursextrem 0.0012](/images/extremecours_fleche.png)
Manager | Titel | Alter | Seit |
---|---|---|---|
Neilank K. Jha
CEO | Chief Executive Officer | - | 12.12. |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
Chadwick Harman
COO | Chief Operating Officer | - | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bruce Cassidy
BRD | Director/Board Member | 74 | - |
Michael Gurin
BRD | Director/Board Member | - | - |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
% 1. Jan. | Kap. | |
---|---|---|
-98.06% | 878’721 | |
+34.14% | 51.12 Mrd. | |
-6.54% | 39.4 Mrd. | |
+34.92% | 38.48 Mrd. | |
+12.62% | 26.36 Mrd. | |
-12.11% | 26.22 Mrd. | |
-13.43% | 20.96 Mrd. | |
+43.73% | 14.02 Mrd. | |
+31.81% | 12.49 Mrd. | |
-4.54% | 11.61 Mrd. |